drugset / Trial / NCT07534592

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

NCT07534592

Phase 1 Active not recruiting 48 enrolled AstraZeneca Parexel · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

The study has 2 groups, one each focusing on co-administration of elecoglipron and atorvastatin or rosuvastatin to assess the pharmacokinetics (PK) of atorvastatin in healthy participants.

Timeline

Start
2026-04-16
Primary completion
2026-08-28
Completion
2026-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule Oral
Subject Elecoglipron Unknown Oral
Subject Rosuvastatin Small molecule Oral

Indications

No indication recorded.